Reblozyl : Orphan maintenance assessment report (post authorisation)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
orphan-maintenance-report-post
medication.label.permit_number
EMA/OD/0000072540
medication.label.permit_validity
First published: 2023-03-20T16:37:00Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live